
|Articles|July 10, 2015
Rep. Frank Pallone Jr. on Streamlining the Anti-Cancer Drug Approval Process
Author(s)Rep. Frank Pallone Jr.
Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses "streamlining" the FDA's drug approval process as it relates to the 21st Century Cures Act.
Advertisement
Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses “streamlining” the FDA’s drug approval process as it relates to the 21st Century Cures Act.
In a 344-77 vote this morning, the U.S. House of Representatives voted overwhelmingly to approve the 21st Century Cures Act.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
New Combination Treatment Approach Studied in Pancreatic Cancer
5




